[Natural course of HPV infection. Usefulness of HPV analysis in cervix diagnosis].

Standard

[Natural course of HPV infection. Usefulness of HPV analysis in cervix diagnosis]. / Milde-Langosch, K; Riethdorf, Sabine; Park, T W.

In: PATHOLOGE, Vol. 20, No. 1, 1, 1999, p. 15-24.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{df6b662b2edb477ca4d5ff3d5d4c7894,
title = "[Natural course of HPV infection. Usefulness of HPV analysis in cervix diagnosis].",
abstract = "Cervical carcinomas and their precursors (cervical dysplasia, CIN1-3) are associated with human papillomavirus (HPV) infections. Epidemiological and in vitro-studies have shown that some of the genital HPV types, the high risk-types 16, 18, 31 etc., code for proteins (E6/E7) which strongly influence the cell cycle and genome stability. Progression from weak to severe dysplasia and to invasive cancer is associated with increasing expression of these viral oncogenes. Which additional cofactors contribute to progression of some dysplasias to carcinomas is still a matter of investigation. Recent results point to genetic predisposition (p53 polymorphism), cellular immune reaction, and cytokine expression. For HPV detection in cervical swabs and biopsies two highly sensitive and reliable systems (PCR, Hybrid Capture system) are available. Although classical histological methods are sufficient for the diagnosis of high-grade lesions and invasive cancer, HPV testing might give valuable diagnostic and prognostic clues especially in cases of unclear cytology (ASCUS) or weak dysplasia.",
keywords = "Biopsy, Humans, Female, Risk Factors, Cell Transformation, Neoplastic/pathology, Cervical Intraepithelial Neoplasia/pathology, Cervix Uteri/pathology, *Papillomaviridae/genetics/pathogenicity, Papillomavirus Infections/*pathology, Precancerous Conditions/pathology, Tumor Virus Infections/*pathology, Uterine Cervical Dysplasia/pathology, Uterine Cervical Neoplasms/*pathology, Virulence/genetics, Biopsy, Humans, Female, Risk Factors, Cell Transformation, Neoplastic/pathology, Cervical Intraepithelial Neoplasia/pathology, Cervix Uteri/pathology, *Papillomaviridae/genetics/pathogenicity, Papillomavirus Infections/*pathology, Precancerous Conditions/pathology, Tumor Virus Infections/*pathology, Uterine Cervical Dysplasia/pathology, Uterine Cervical Neoplasms/*pathology, Virulence/genetics",
author = "K Milde-Langosch and Sabine Riethdorf and Park, {T W}",
year = "1999",
language = "Deutsch",
volume = "20",
pages = "15--24",
journal = "PATHOLOGE",
issn = "0172-8113",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - [Natural course of HPV infection. Usefulness of HPV analysis in cervix diagnosis].

AU - Milde-Langosch, K

AU - Riethdorf, Sabine

AU - Park, T W

PY - 1999

Y1 - 1999

N2 - Cervical carcinomas and their precursors (cervical dysplasia, CIN1-3) are associated with human papillomavirus (HPV) infections. Epidemiological and in vitro-studies have shown that some of the genital HPV types, the high risk-types 16, 18, 31 etc., code for proteins (E6/E7) which strongly influence the cell cycle and genome stability. Progression from weak to severe dysplasia and to invasive cancer is associated with increasing expression of these viral oncogenes. Which additional cofactors contribute to progression of some dysplasias to carcinomas is still a matter of investigation. Recent results point to genetic predisposition (p53 polymorphism), cellular immune reaction, and cytokine expression. For HPV detection in cervical swabs and biopsies two highly sensitive and reliable systems (PCR, Hybrid Capture system) are available. Although classical histological methods are sufficient for the diagnosis of high-grade lesions and invasive cancer, HPV testing might give valuable diagnostic and prognostic clues especially in cases of unclear cytology (ASCUS) or weak dysplasia.

AB - Cervical carcinomas and their precursors (cervical dysplasia, CIN1-3) are associated with human papillomavirus (HPV) infections. Epidemiological and in vitro-studies have shown that some of the genital HPV types, the high risk-types 16, 18, 31 etc., code for proteins (E6/E7) which strongly influence the cell cycle and genome stability. Progression from weak to severe dysplasia and to invasive cancer is associated with increasing expression of these viral oncogenes. Which additional cofactors contribute to progression of some dysplasias to carcinomas is still a matter of investigation. Recent results point to genetic predisposition (p53 polymorphism), cellular immune reaction, and cytokine expression. For HPV detection in cervical swabs and biopsies two highly sensitive and reliable systems (PCR, Hybrid Capture system) are available. Although classical histological methods are sufficient for the diagnosis of high-grade lesions and invasive cancer, HPV testing might give valuable diagnostic and prognostic clues especially in cases of unclear cytology (ASCUS) or weak dysplasia.

KW - Biopsy

KW - Humans

KW - Female

KW - Risk Factors

KW - Cell Transformation, Neoplastic/pathology

KW - Cervical Intraepithelial Neoplasia/pathology

KW - Cervix Uteri/pathology

KW - Papillomaviridae/genetics/pathogenicity

KW - Papillomavirus Infections/pathology

KW - Precancerous Conditions/pathology

KW - Tumor Virus Infections/pathology

KW - Uterine Cervical Dysplasia/pathology

KW - Uterine Cervical Neoplasms/pathology

KW - Virulence/genetics

KW - Biopsy

KW - Humans

KW - Female

KW - Risk Factors

KW - Cell Transformation, Neoplastic/pathology

KW - Cervical Intraepithelial Neoplasia/pathology

KW - Cervix Uteri/pathology

KW - Papillomaviridae/genetics/pathogenicity

KW - Papillomavirus Infections/pathology

KW - Precancerous Conditions/pathology

KW - Tumor Virus Infections/pathology

KW - Uterine Cervical Dysplasia/pathology

KW - Uterine Cervical Neoplasms/pathology

KW - Virulence/genetics

M3 - SCORING: Zeitschriftenaufsatz

VL - 20

SP - 15

EP - 24

JO - PATHOLOGE

JF - PATHOLOGE

SN - 0172-8113

IS - 1

M1 - 1

ER -